UEEC (UNITED HEALTH PRODUCTS) COULD POTENTIALLY BE BOUGHT OUT
Post# of 103015
(Total Views: 347)
Posted On: 06/19/2017 6:00:07 PM
UEEC (UNITED HEALTH PRODUCTS) COULD POTENTIALLY BE BOUGHT WITH FDA APPROVAL!!
First let me start by saying that I have been fortunate to make a lot of money in this market for many years (except in 2008 when everyone lost). Some of my most memorable trades have been
GNTA (GENTA PHARMA .20-1.20)
HGSI (HUMAN GENOME SCIENCES 3.00- 15.75)
KFN (3.50- 8.00)
AMRN (AMARIN CORP 2.50- 19.00 BIGGEST GAIN)
VTUS (VENTRUS BIOSCIENCES 3.00- 13.00 GOT OUT BEFORE THE NEGATIVE NEWS)
KITE (OPTIONED 60.00 – 88.00
UEEC could potentially bigger than all of these previous trades of mine. Its completely undervalued and not a lot of people know about it. This is a unique gauze that stands alone in its class. It had tremendous lab results about a year ago and distributors have been buying up the pad left and right. Total Resource International has even signed a MULTIMILLION DOLLAR DEAL with United Health Products. In life, everything evolves. This gauze has changed the game and could potentially take over the market not only because it stops bleeding faster than all its competitors ITS ALL NATURAL. ALL NATURAL, that’s the difference. Because it is all natural they have submitted an application to the FDA for GENERAL SURGERY which is a 16-billion-dollar market. They are already FDA class ll approved and with those impressive lab results a year ago, I can’t see how they don’t get this next approval. I’ve researched and haven’t seen a gauze out that is approved for general surgery. With FDA approval (in my opinion) UEEC IS A POTENTIAL BUYOUT WAITING TO HAPPEN.
First let me start by saying that I have been fortunate to make a lot of money in this market for many years (except in 2008 when everyone lost). Some of my most memorable trades have been
GNTA (GENTA PHARMA .20-1.20)
HGSI (HUMAN GENOME SCIENCES 3.00- 15.75)
KFN (3.50- 8.00)
AMRN (AMARIN CORP 2.50- 19.00 BIGGEST GAIN)
VTUS (VENTRUS BIOSCIENCES 3.00- 13.00 GOT OUT BEFORE THE NEGATIVE NEWS)
KITE (OPTIONED 60.00 – 88.00
UEEC could potentially bigger than all of these previous trades of mine. Its completely undervalued and not a lot of people know about it. This is a unique gauze that stands alone in its class. It had tremendous lab results about a year ago and distributors have been buying up the pad left and right. Total Resource International has even signed a MULTIMILLION DOLLAR DEAL with United Health Products. In life, everything evolves. This gauze has changed the game and could potentially take over the market not only because it stops bleeding faster than all its competitors ITS ALL NATURAL. ALL NATURAL, that’s the difference. Because it is all natural they have submitted an application to the FDA for GENERAL SURGERY which is a 16-billion-dollar market. They are already FDA class ll approved and with those impressive lab results a year ago, I can’t see how they don’t get this next approval. I’ve researched and haven’t seen a gauze out that is approved for general surgery. With FDA approval (in my opinion) UEEC IS A POTENTIAL BUYOUT WAITING TO HAPPEN.
(0)
(0)Scroll down for more posts ▼